Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    18270337 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer;   Oropharyngeal Cancer;   Human Papillomavirus;   Squamous Cell Cancer
Intervention:
2 Unknown  Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Condition: Head and Neck Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
3 Terminated Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Condition: Oropharyngeal Neoplasms
Interventions: Drug: chemotherapy;   Radiation: radiotherapy;   Radiation: Reduced dose radiotherapy
4 Recruiting The Quarterback Trial
Condition: Squamous Cell Carcinomas
Interventions: Radiation: Reduced Dose Radiation;   Radiation: Standard Dose Radiation

Indicates status has not been verified in more than two years